Suchergebnisse - "Yu, Delia"

PubPharm (11)

1

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003) : 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Global health | 2024

von Tricou, V. | Yu, D. | Reynales, H. | +29

2

Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line : A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age

enthalten in: Human vaccines & immunotherapeutics | 2022

von Ong-Lim, A. | Shukarev, G. | Trinidad-Aseron, M. | +10

3

Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Rivera, L. | Biswal, S. | Sáez-Llorens, X. | +27

4

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

enthalten in: The Journal of infectious diseases | 2022

von López-Medina, E. | Biswal, S. | Saez-Llorens, X. | +27

5

Safety of primary immunization with a DTwP-HBV/Hib vaccine in healthy infants : a prospective, open-label, interventional, phase IV clinical study

enthalten in: Expert review of vaccines | 2022

von Capeding, M. | Gatchalian, S. | Aseron, M. | +7

6

Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years : a randomised, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2020

von Biswal, S. | Borja-Tabora, C. | Martinez Vargas, L. | +67

CommentIn: Lancet. 2020 May 2;395(10234):1402-1404. - PMID 32197106

7

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years : a randomised, placebo-controlled, phase 2 trial

enthalten in: Lancet (London, England) | 2020

von Tricou, V. | Sáez-Llorens, X. | Yu, D. | +16

CommentIn: Lancet. 2020 May 2;395(10234):1402-1404. - PMID 32197106

8

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

enthalten in: The New England journal of medicine | 2019

von Biswal, S. | Reynales, H. | Saez-Llorens, X. | +39

CommentIn: N Engl J Med. 2020 Apr 30;382(18):1769. - PMID 32348658

9

Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week : Results from a phase III clinical trial in children, adolescents and adults

enthalten in: PLoS neglected tropical diseases | 2018

von Kerdpanich, P. | Chanthavanich, P. | De Los Reyes, M. | +7

10

Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America : 18-month interim data from a phase 2, randomised, placebo-controlled study

enthalten in: The Lancet. Infectious diseases | 2018

von Sáez-Llorens, X. | Tricou, V. | Yu, D. | +11

CommentIn: Lancet Infect Dis. 2018 Feb;18(2):125-126. - PMID 29122464